Dyneval, the Roslin-based biotechnology start-up, has secured more than £1.8 million of funding from investors as it expands its team and gears up to launch its first product at the start of 2022. The company has raised £1.29m of Series A equity investment through a collaborative funding
Cottagequinn Enterprises Ltd
1-1 of 1 Articles